261 related articles for article (PubMed ID: 25733806)
1. Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.
Qiu JX; Zhou ZW; He ZX; Zhang X; Zhou SF; Zhu S
Drug Des Devel Ther; 2015; 9():841-66. PubMed ID: 25733806
[TBL] [Abstract][Full Text] [Related]
2. Pungent ginger components modulates human cytochrome P450 enzymes in vitro.
Li M; Chen PZ; Yue QX; Li JQ; Chu RA; Zhang W; Wang H
Acta Pharmacol Sin; 2013 Sep; 34(9):1237-42. PubMed ID: 23770984
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Herb-Drug Interaction (HDI) Potential of
Husain I; Dale OR; Idrisi M; Gurley BJ; Avula B; Katragunta K; Ali Z; Chittiboyina A; Noonan G; Khan IA; Khan SI
J Agric Food Chem; 2023 May; 71(19):7521-7534. PubMed ID: 37134183
[TBL] [Abstract][Full Text] [Related]
5. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cytochrome P450-mediated drug-drug interaction potential of orteronel and exposure changes in patients with renal impairment using physiologically based pharmacokinetic modeling and simulation.
Lu C; Suri A; Shyu WC; Prakash S
Biopharm Drug Dispos; 2014 Dec; 35(9):543-52. PubMed ID: 25264242
[TBL] [Abstract][Full Text] [Related]
7. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Br J Pharmacol; 2003 Apr; 138(8):1465-74. PubMed ID: 12721102
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.
Pea F; Furlanut M
Clin Pharmacokinet; 2001; 40(11):833-68. PubMed ID: 11735605
[TBL] [Abstract][Full Text] [Related]
9. Effects of an aqueous-ethanolic extract of ginger on cytochrome P450 enzyme-mediated drug metabolism.
Kim IS; Kim SY; Yoo HH
Pharmazie; 2012 Dec; 67(12):1007-9. PubMed ID: 23346764
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics.
Mukkavilli R; Gundala SR; Yang C; Donthamsetty S; Cantuaria G; Jadhav GR; Vangala S; Reid MD; Aneja R
PLoS One; 2014; 9(9):e108386. PubMed ID: 25251219
[TBL] [Abstract][Full Text] [Related]
11. Investigation of sarizotan's impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial.
Krösser S; Neugebauer R; Dolgos H; Fluck M; Rost KL; Kovar A
Eur J Clin Pharmacol; 2006 Apr; 62(4):277-84. PubMed ID: 16525816
[TBL] [Abstract][Full Text] [Related]
12. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
[TBL] [Abstract][Full Text] [Related]
13. Identification and in silico prediction of metabolites of tebufenozide derivatives by major human cytochrome P450 isoforms.
Edamatsu H; Yagawa M; Ikushiro S; Sakaki T; Nakagawa Y; Miyagawa H; Akamatsu M
Bioorg Med Chem; 2020 May; 28(9):115429. PubMed ID: 32201191
[TBL] [Abstract][Full Text] [Related]
14. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD.
He X; Luo X; Liu Z; Hu G; Cheng Z
Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010
[TBL] [Abstract][Full Text] [Related]
15. Ginger (Zingiber officinale) phytochemicals-gingerenone-A and shogaol inhibit SaHPPK: molecular docking, molecular dynamics simulations and in vitro approaches.
Rampogu S; Baek A; Gajula RG; Zeb A; Bavi RS; Kumar R; Kim Y; Kwon YJ; Lee KW
Ann Clin Microbiol Antimicrob; 2018 Apr; 17(1):16. PubMed ID: 29609660
[TBL] [Abstract][Full Text] [Related]
16. Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects.
Darwish M; Kirby M; Robertson P; Hellriegel ET
Clin Pharmacokinet; 2008; 47(1):61-74. PubMed ID: 18076219
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
Bournique B; Lambert N; Boukaiba R; Martinet M
Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
[TBL] [Abstract][Full Text] [Related]
18. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
Liu R; Liu J; Tawa G; Wallqvist A
J Chem Inf Model; 2012 Jun; 52(6):1698-712. PubMed ID: 22631565
[TBL] [Abstract][Full Text] [Related]
19. Active components of ginger potentiate β-agonist-induced relaxation of airway smooth muscle by modulating cytoskeletal regulatory proteins.
Townsend EA; Zhang Y; Xu C; Wakita R; Emala CW
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):115-24. PubMed ID: 23962082
[TBL] [Abstract][Full Text] [Related]
20. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
McGinnity DF; Parker AJ; Soars M; Riley RJ
Drug Metab Dispos; 2000 Nov; 28(11):1327-34. PubMed ID: 11038161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
